Savara SVRA
NASDAQ SVRA
$5.16 +0.08 (+1.57%)
At close: Sep 30, 2026 · 4:00 PM EDT

Savara (SVRA) Deferred Taxes (2018)

Updated

Savara (SVRA) posted Deferred Taxes of -$2.5 million for Q4 2018.

Analysis

Savara (SVRA) Deferred Taxes (2018) Analysis & Trends

For FY2018, Savara's Deferred Taxes came in at -$7.06 million.

  • In prior years, Savara's Deferred Taxes was -$2.82 million in FY2017 and -$2.41 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -479.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -195.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -587.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Savara 1.06 Bn 1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -2.50 Mn
Mar 31, 2018 -4.56 Mn
API Access

Savara Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=SVRA&period=max&api_key=YOUR_API_KEY